Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study
暂无分享,去创建一个
K. Ohta | M. Adachi | M. Ichinose | Y. Tohda | P. Moroni-Zentgraf | M. Engel | S. Kunimitsu | W. Sakamoto
[1] A. Woodcock,et al. Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone , 2013, Thorax.
[2] G. Pledger,et al. Tiotropium Respimat inhaler and the risk of death in COPD. , 2013, The New England journal of medicine.
[3] E. Bleecker,et al. Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate , 2013 .
[4] E. Bateman,et al. Systematic review and meta-analysis of the magnitude of the effect on AQLQ and ACQ in asthma clinical trials , 2013 .
[5] Michael Engel,et al. Tiotropium in asthma poorly controlled with standard combination therapy. , 2012, The New England journal of medicine.
[6] H. Kerstjens,et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. , 2011, The Journal of allergy and clinical immunology.
[7] E. Bateman,et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. , 2011, The Journal of allergy and clinical immunology.
[8] M. Decramer,et al. Efficacy of tiotropium in COPD patients from Asia: A subgroup analysis from the UPLIFT trial , 2011, Respirology.
[9] D. Olivieri,et al. Understanding patients with asthma and COPD: insights from a European study. , 2011, Primary care respiratory journal : journal of the General Practice Airways Group.
[10] K. Ohta,et al. Japanese guideline for adult asthma. , 2011, Allergology international : official journal of the Japanese Society of Allergology.
[11] E. R. Sutherland,et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. , 2010, The New England journal of medicine.
[12] T. Lasserson,et al. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. , 2010, The Cochrane database of systematic reviews.
[13] P. Demoly,et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK , 2009, European Respiratory Review.
[14] M. Decramer,et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[15] C. Furberg,et al. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2008, JAMA.
[16] R. Pauwels,et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.
[17] D. Fabian,et al. The global burden of asthma: executive summary of the GINA Dissemination Committee Report , 2004, Allergy.
[18] Jing Tian,et al. Synergism between rhinovirus infection and oxidant pollutant exposure enhances airway epithelial cell cytokine production. , 2002, Environmental health perspectives.
[19] A. Fendrick,et al. Respiratory illness caused by picornavirus infection: a review of clinical outcomes , 2001, Clinical Therapeutics.
[20] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .